FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Jul 8, 2025 - 15:00
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
Merck's shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.